Invention Grant
- Patent Title: Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
-
Application No.: US16040592Application Date: 2018-07-20
-
Publication No.: US10588941B2Publication Date: 2020-03-17
- Inventor: Na Xiong , Mingcan Xia
- Applicant: The Penn State Research Foundation
- Applicant Address: US PA University Park
- Assignee: THE PENN STATE RESEARCH FOUNDATION
- Current Assignee: THE PENN STATE RESEARCH FOUNDATION
- Current Assignee Address: US PA University Park
- Agency: Riverside Law LLP
- Main IPC: A61K38/19
- IPC: A61K38/19 ; C07K14/52 ; C07K14/715 ; C12N15/113 ; A61K45/06

Abstract:
The invention provides compositions and methods for targeting CCR10 and/or the CCR10/ligand axis to modulate the immune response in a subject.
Public/Granted literature
- US20180327754A1 Modulation of CCR10 Signals for Treatment of Skin and Intestinal Inflammatory Diseases and Infection Public/Granted day:2018-11-15
Information query
IPC分类: